A retrospective analysis for the predictive factors for severe adverse event in the patients of advanced non-small cell lung cancer who treated with anti-PD-1 antibody
Not Applicable
- Conditions
- non-small cell lung cancer
- Registration Number
- JPRN-UMIN000033826
- Lead Sponsor
- Kansai Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
Patients refused to participate of this study, judged as inappropriate by principal investigator.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method incidence of severe adverse events
- Secondary Outcome Measures
Name Time Method response rate, progression-free survival